Annual report pursuant to Section 13 and 15(d)

Warrants (Tables)

v3.21.1
Warrants (Tables)
12 Months Ended
Dec. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Schedule of outstanding warrants and changes in fair value
The following illustrates the Company's outstanding warrants to purchase shares of the Company's common stock as of and for the years ending December 31, 2020 and 2019:
Warrants Exercise Price
Warrants acquired on May 6, 2019 712,823  $ 3.90 
Issued 17,414,030  $ 3.27 
Exercised (1,144,999) $ 3.50 
Warrants outstanding as of December 31, 2019 16,981,854  $ 3.23 
Issued 49,928,469  $ 0.77 
Exercised (1,937,690) $ 0.58 
Terminated/Expired (5,470,655) $ 3.07 
Warrants outstanding as of December 31, 2020 59,501,978  $ 1.22 
The following schedules show the fair value of the warrant derivative liability as of December 31, 2020 and 2019, and the change in fair value during the years ended December 31, 2020 and 2019 (in thousands):
Warrant Derivative Liability
Assumption of warrants in May Acquisitions $ 2,130 
Change in fair value of warrant derivative liability 90 
Balance as of December 31, 2019 $ 2,220 
Change in fair value of  warrant derivative liability (2,220)
Balance as of December 31, 2020 $ — 
The following schedule shows the fair value of the warrant liability upon issuance and the change in fair value during the year ended December 31, 2020 (in thousands):
Warrant Liability
Issuance of Series F warrants $ 14,952 
Change in fair value of warrant liability 24,898 
Balance as of December 31, 2020 $ 39,850 
Schedule of fair value measurement inputs
The following schedule shows the inputs used to measure the fair value of the warrant liability as of December 31, 2020:
Warrant liability December 31, 2020
Stock price $ 1.27 
Exercise price $ 0.75 
Expected remaining term (in years)
5.75 – 5.81
Volatility 67.5  %
Risk-free interest rate 0.5  %